id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-329219-7mfi16rd	Gisondi, P.	The impact of the COVID‐19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience	2020-05-28		.txt	text/plain	1054	59	51	authors: Gisondi, P.; Facheris, P.; Dapavo, P.; Piaserico, S.; Conti, A.; Naldi, L.; Cazzaniga, S.; Malagoli, P.; Costanzo, A. [4] [5] [6] We performed a retrospective multicentre observational study, which included patients with chronic plaque psoriasis (n = 5206) who were being treated with biological therapy, with the objective of reporting the number of patients hospitalized or who died from COVID-19 infection between 20 February 2020 and 1 April 2020. The inclusion criteria for the study were patients with psoriasis who were being regularly followed at the Divisions of Dermatology at the hospitals of Verona, Padua, Vicenza, Modena, Turin or Milan (Humanitas and San Donato hospitals) and were being treated with a biologic, including tumour necrosis factor-a, interleukin (IL)-17, IL-12/23 or IL-23 inhibitors. Although patients with psoriasis are generally burdened by metabolic and cardiovascular comorbidities and, most importantly, treated with immunosuppressive/immunomodulating agents, there was not a significant number of hospitalizations or deaths from COVID-19.	./cache/cord-329219-7mfi16rd.txt	./txt/cord-329219-7mfi16rd.txt